DJIA 15,335.28 -19.12 -0.12%
NASDAQ 3,496.43 -2.54 -0.07%
S&P 500 1,666.29 -1.18 -0.07%

Sarepta Therapeutics

NASDAQ: SRPT

37.13 0.22 (0.60%)

Quote as of

company name or ticker

Recent Quotes

SRPT $37.13 0.60%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $37.02
Previous Close $36.91
Daily Range $36.90 - $37.80
52-Week Range $2.60 - $45.00
Market Cap $1.2B
P/E Ratio -6.50
Dividend (Yield) $0.00 (0.0%)
Volume 1,160,649
Average Daily Volume 2,189,627
Current FY EPS -$3.68

Sector

Healthcare

Industry

Drugs

Sarepta Therapeutics (SRPT) Description

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology. Website: http://www.sareptatherapeutics.com/

News & Commentary

Sarepta Therapeutics Inc (SRPT): Today's Featured Drugs Winner

2 BioPharma Catalyst Trades Set to Break-Out With One Strong Acquisition Target

2 BioPharma Catalyst Trades And 1 Strong Acquisition Target Rumored To Be In Play

3 Biotech Stocks With Potential

Biotech Stock Mailbag: Synta, Zogenix, Sarepta, Amarin

Sarepta Therapeutics' CEO Discusses Q1 2013 Results - Earnings Call Transcript

Leaders of TheStreet's Drug Approval Contest

April's Unhealthiest Stocks

These three health-care picks nosedived last month on earnings and disappointing drug data.

3 Biggest Biotech Crashes in April

When biotechs fall, they fall hard. These three fell the hardest in April.

Sarepta Therapeutics Inc (SRPT): Today's Featured Drugs Winner

See More SRPT News...

SRPT's Top Competitors

SRPT $37.13 (0.60%)
Current stock: SRPT
AMGN $102.18 (-3.27%)
Current stock: AMGN
GILD $55.74 (-0.99%)
Current stock: GILD
BIIB $225.18 (-0.74%)
Current stock: BIIB